Word: enterococci
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...infectious diseases, pharmaceutical companies have begun to comb through the vast chemical libraries assembled over the past decade in search of new antimicrobial agents. The effort is starting to pay off. Since September 1999, the U.S. Food and Drug Administration has approved two new antibiotics that target both the enterococci and staphylococci. One--linezolid--seems particularly promising; it represents the first new class of antibiotics to come on the market in 35 years...
Both daptomycin and linezolid (branded under the trade names Cidecin and Zyvox) are aimed at drug-resistant enterococci and staphylococci, which have ballooned into a huge problem for nursing homes and hospitals. But while that is the most attractive commercial market, a number of American pharmaceutical companies are also participating in private-public partnerships aimed at resolving the global health crisis created by drug-resistant malaria and TB. At present, neither disease is a tremendous problem in the U.S. or Western Europe, but that happy situation may not last forever, especially where TB is concerned. In 1992, at the height...
| 1 |